DIA Europe is an event for all life science professionals working in drug development, from discovery to marketed use. The program includes topics designed to advance healthcare priorities and outcomes through innovation.
TransCelerate’s Intelligent Automation Opportunities in Pharmacovigilance (IAO) will conduct a session on “Strategies to Implement Routine Intelligent Automation Technologies within Pharmacovigilance for the ICSR Process,” led by GSK’s Raymond Kassekert. The session will occur on March 16 from 18:15-19:15.
IAO’s Kristof Huysentruyt (UCB) will participate in a DIAmond Session hosted by MHRA’s Phil Tregunno titled “The Use of Artificial Intelligence/ Machine Learning in Pharmacovigilance.” He will be joined by another IAO member, Andrew Bate (GSK), and the FDA’s Gerald Dal Pan.